nodes	percent_of_prediction	percent_of_DWPC	metapath
Thalidomide—PTGS2—Barrett's esophagus	0.336	1	CbGaD
Thalidomide—CYP1A1—Omeprazole—Barrett's esophagus	0.121	0.317	CbGbCtD
Thalidomide—CYP2C19—Esomeprazole—Barrett's esophagus	0.0991	0.26	CbGbCtD
Thalidomide—CYP2C19—Omeprazole—Barrett's esophagus	0.0584	0.153	CbGbCtD
Thalidomide—CYP1A2—Omeprazole—Barrett's esophagus	0.0539	0.142	CbGbCtD
Thalidomide—CYP2C9—Omeprazole—Barrett's esophagus	0.0485	0.128	CbGbCtD
Thalidomide—FGFR2—exocrine gland—Barrett's esophagus	0.00488	0.216	CbGeAlD
Thalidomide—NFKB1—digestive system—Barrett's esophagus	0.00215	0.0953	CbGeAlD
Thalidomide—FGFR2—epithelium—Barrett's esophagus	0.00212	0.0941	CbGeAlD
Thalidomide—FGFR2—smooth muscle tissue—Barrett's esophagus	0.00205	0.0907	CbGeAlD
Thalidomide—CRBN—digestive system—Barrett's esophagus	0.0018	0.0799	CbGeAlD
Thalidomide—Lenalidomide—PTGS2—Barrett's esophagus	0.00177	0.518	CrCbGaD
Thalidomide—Pomalidomide—PTGS2—Barrett's esophagus	0.00165	0.482	CrCbGaD
Thalidomide—FGFR2—digestive system—Barrett's esophagus	0.00161	0.0716	CbGeAlD
Thalidomide—CYP1A1—epithelium—Barrett's esophagus	0.000768	0.0341	CbGeAlD
Thalidomide—CYP2C19—digestive system—Barrett's esophagus	0.000725	0.0322	CbGeAlD
Thalidomide—PTGS1—epithelium—Barrett's esophagus	0.000675	0.0299	CbGeAlD
Thalidomide—PTGS1—smooth muscle tissue—Barrett's esophagus	0.00065	0.0288	CbGeAlD
Thalidomide—PTGS2—epithelium—Barrett's esophagus	0.000645	0.0286	CbGeAlD
Thalidomide—PTGS2—smooth muscle tissue—Barrett's esophagus	0.000622	0.0276	CbGeAlD
Thalidomide—CYP1A2—digestive system—Barrett's esophagus	0.000592	0.0263	CbGeAlD
Thalidomide—CYP1A1—digestive system—Barrett's esophagus	0.000584	0.0259	CbGeAlD
Thalidomide—Injury—Omeprazole—Barrett's esophagus	0.000577	0.00333	CcSEcCtD
Thalidomide—Injury—Esomeprazole—Barrett's esophagus	0.000577	0.00333	CcSEcCtD
Thalidomide—CYP3A5—digestive system—Barrett's esophagus	0.000571	0.0253	CbGeAlD
Thalidomide—Increased appetite—Omeprazole—Barrett's esophagus	0.000564	0.00326	CcSEcCtD
Thalidomide—Increased appetite—Esomeprazole—Barrett's esophagus	0.000564	0.00326	CcSEcCtD
Thalidomide—CYP2C9—digestive system—Barrett's esophagus	0.000562	0.0249	CbGeAlD
Thalidomide—Visual disturbance—Esomeprazole—Barrett's esophagus	0.000559	0.00323	CcSEcCtD
Thalidomide—Visual disturbance—Omeprazole—Barrett's esophagus	0.000559	0.00323	CcSEcCtD
Thalidomide—Purpura—Esomeprazole—Barrett's esophagus	0.00055	0.00317	CcSEcCtD
Thalidomide—Purpura—Omeprazole—Barrett's esophagus	0.00055	0.00317	CcSEcCtD
Thalidomide—Arthritis—Omeprazole—Barrett's esophagus	0.000545	0.00315	CcSEcCtD
Thalidomide—Arthritis—Esomeprazole—Barrett's esophagus	0.000545	0.00315	CcSEcCtD
Thalidomide—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.000543	0.00313	CcSEcCtD
Thalidomide—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.000543	0.00313	CcSEcCtD
Thalidomide—CYP2E1—digestive system—Barrett's esophagus	0.000533	0.0236	CbGeAlD
Thalidomide—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.000532	0.00307	CcSEcCtD
Thalidomide—Hyponatraemia—Omeprazole—Barrett's esophagus	0.000532	0.00307	CcSEcCtD
Thalidomide—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00053	0.00306	CcSEcCtD
Thalidomide—Diplopia—Esomeprazole—Barrett's esophagus	0.00053	0.00306	CcSEcCtD
Thalidomide—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00053	0.00306	CcSEcCtD
Thalidomide—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00053	0.00306	CcSEcCtD
Thalidomide—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00053	0.00306	CcSEcCtD
Thalidomide—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00053	0.00306	CcSEcCtD
Thalidomide—Diplopia—Omeprazole—Barrett's esophagus	0.00053	0.00306	CcSEcCtD
Thalidomide—Pain in extremity—Omeprazole—Barrett's esophagus	0.00053	0.00306	CcSEcCtD
Thalidomide—Migraine—Omeprazole—Barrett's esophagus	0.000522	0.00301	CcSEcCtD
Thalidomide—Migraine—Esomeprazole—Barrett's esophagus	0.000522	0.00301	CcSEcCtD
Thalidomide—PTGS1—digestive system—Barrett's esophagus	0.000513	0.0228	CbGeAlD
Thalidomide—Face oedema—Esomeprazole—Barrett's esophagus	0.000512	0.00295	CcSEcCtD
Thalidomide—Face oedema—Omeprazole—Barrett's esophagus	0.000512	0.00295	CcSEcCtD
Thalidomide—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.000497	0.00287	CcSEcCtD
Thalidomide—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.000497	0.00287	CcSEcCtD
Thalidomide—PTGS2—digestive system—Barrett's esophagus	0.000491	0.0218	CbGeAlD
Thalidomide—Dry skin—Esomeprazole—Barrett's esophagus	0.000486	0.0028	CcSEcCtD
Thalidomide—Dry skin—Omeprazole—Barrett's esophagus	0.000486	0.0028	CcSEcCtD
Thalidomide—Hypokalaemia—Omeprazole—Barrett's esophagus	0.000482	0.00278	CcSEcCtD
Thalidomide—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.000482	0.00278	CcSEcCtD
Thalidomide—Breast disorder—Esomeprazole—Barrett's esophagus	0.000479	0.00276	CcSEcCtD
Thalidomide—Breast disorder—Omeprazole—Barrett's esophagus	0.000479	0.00276	CcSEcCtD
Thalidomide—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000477	0.00275	CcSEcCtD
Thalidomide—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.000477	0.00275	CcSEcCtD
Thalidomide—Cramp muscle—Esomeprazole—Barrett's esophagus	0.000477	0.00275	CcSEcCtD
Thalidomide—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000477	0.00275	CcSEcCtD
Thalidomide—Cramp muscle—Omeprazole—Barrett's esophagus	0.000477	0.00275	CcSEcCtD
Thalidomide—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000477	0.00275	CcSEcCtD
Thalidomide—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000468	0.0027	CcSEcCtD
Thalidomide—Muscular weakness—Esomeprazole—Barrett's esophagus	0.000468	0.0027	CcSEcCtD
Thalidomide—Muscular weakness—Omeprazole—Barrett's esophagus	0.000468	0.0027	CcSEcCtD
Thalidomide—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000468	0.0027	CcSEcCtD
Thalidomide—Abdominal distension—Esomeprazole—Barrett's esophagus	0.000461	0.00266	CcSEcCtD
Thalidomide—Abdominal distension—Omeprazole—Barrett's esophagus	0.000461	0.00266	CcSEcCtD
Thalidomide—Dysphagia—Omeprazole—Barrett's esophagus	0.000458	0.00264	CcSEcCtD
Thalidomide—Influenza—Omeprazole—Barrett's esophagus	0.000458	0.00264	CcSEcCtD
Thalidomide—Dysphagia—Esomeprazole—Barrett's esophagus	0.000458	0.00264	CcSEcCtD
Thalidomide—Influenza—Esomeprazole—Barrett's esophagus	0.000458	0.00264	CcSEcCtD
Thalidomide—Bronchospasm—Omeprazole—Barrett's esophagus	0.000451	0.0026	CcSEcCtD
Thalidomide—Bronchospasm—Esomeprazole—Barrett's esophagus	0.000451	0.0026	CcSEcCtD
Thalidomide—Pancreatitis—Omeprazole—Barrett's esophagus	0.000449	0.00259	CcSEcCtD
Thalidomide—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000449	0.00259	CcSEcCtD
Thalidomide—Angina pectoris—Omeprazole—Barrett's esophagus	0.000446	0.00258	CcSEcCtD
Thalidomide—Angina pectoris—Esomeprazole—Barrett's esophagus	0.000446	0.00258	CcSEcCtD
Thalidomide—Pancytopenia—Omeprazole—Barrett's esophagus	0.000435	0.00251	CcSEcCtD
Thalidomide—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000435	0.00251	CcSEcCtD
Thalidomide—Neutropenia—Omeprazole—Barrett's esophagus	0.000428	0.00247	CcSEcCtD
Thalidomide—Neutropenia—Esomeprazole—Barrett's esophagus	0.000428	0.00247	CcSEcCtD
Thalidomide—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000426	0.00246	CcSEcCtD
Thalidomide—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000426	0.00246	CcSEcCtD
Thalidomide—Pollakiuria—Omeprazole—Barrett's esophagus	0.000423	0.00244	CcSEcCtD
Thalidomide—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000423	0.00244	CcSEcCtD
Thalidomide—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000422	0.00244	CcSEcCtD
Thalidomide—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000422	0.00244	CcSEcCtD
Thalidomide—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000418	0.00241	CcSEcCtD
Thalidomide—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000418	0.00241	CcSEcCtD
Thalidomide—Weight increased—Esomeprazole—Barrett's esophagus	0.000417	0.00241	CcSEcCtD
Thalidomide—Weight increased—Omeprazole—Barrett's esophagus	0.000417	0.00241	CcSEcCtD
Thalidomide—Weight decreased—Esomeprazole—Barrett's esophagus	0.000415	0.00239	CcSEcCtD
Thalidomide—Weight decreased—Omeprazole—Barrett's esophagus	0.000415	0.00239	CcSEcCtD
Thalidomide—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000409	0.00236	CcSEcCtD
Thalidomide—Infestation—Esomeprazole—Barrett's esophagus	0.000409	0.00236	CcSEcCtD
Thalidomide—Infestation NOS—Omeprazole—Barrett's esophagus	0.000409	0.00236	CcSEcCtD
Thalidomide—Infestation—Omeprazole—Barrett's esophagus	0.000409	0.00236	CcSEcCtD
Thalidomide—Depression—Omeprazole—Barrett's esophagus	0.000407	0.00235	CcSEcCtD
Thalidomide—Depression—Esomeprazole—Barrett's esophagus	0.000407	0.00235	CcSEcCtD
Thalidomide—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000405	0.00234	CcSEcCtD
Thalidomide—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000405	0.00234	CcSEcCtD
Thalidomide—Renal failure—Esomeprazole—Barrett's esophagus	0.000402	0.00232	CcSEcCtD
Thalidomide—Renal failure—Omeprazole—Barrett's esophagus	0.000402	0.00232	CcSEcCtD
Thalidomide—Stomatitis—Esomeprazole—Barrett's esophagus	0.000398	0.0023	CcSEcCtD
Thalidomide—Stomatitis—Omeprazole—Barrett's esophagus	0.000398	0.0023	CcSEcCtD
Thalidomide—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000397	0.00229	CcSEcCtD
Thalidomide—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000397	0.00229	CcSEcCtD
Thalidomide—Haematuria—Omeprazole—Barrett's esophagus	0.00039	0.00225	CcSEcCtD
Thalidomide—Haematuria—Esomeprazole—Barrett's esophagus	0.00039	0.00225	CcSEcCtD
Thalidomide—Epistaxis—Esomeprazole—Barrett's esophagus	0.000385	0.00222	CcSEcCtD
Thalidomide—Epistaxis—Omeprazole—Barrett's esophagus	0.000385	0.00222	CcSEcCtD
Thalidomide—Sinusitis—Esomeprazole—Barrett's esophagus	0.000383	0.00221	CcSEcCtD
Thalidomide—Sinusitis—Omeprazole—Barrett's esophagus	0.000383	0.00221	CcSEcCtD
Thalidomide—Agranulocytosis—Omeprazole—Barrett's esophagus	0.000381	0.0022	CcSEcCtD
Thalidomide—Agranulocytosis—Esomeprazole—Barrett's esophagus	0.000381	0.0022	CcSEcCtD
Thalidomide—Bradycardia—Omeprazole—Barrett's esophagus	0.000373	0.00215	CcSEcCtD
Thalidomide—Bradycardia—Esomeprazole—Barrett's esophagus	0.000373	0.00215	CcSEcCtD
Thalidomide—Rhinitis—Esomeprazole—Barrett's esophagus	0.000368	0.00212	CcSEcCtD
Thalidomide—Rhinitis—Omeprazole—Barrett's esophagus	0.000368	0.00212	CcSEcCtD
Thalidomide—Hepatitis—Esomeprazole—Barrett's esophagus	0.000367	0.00212	CcSEcCtD
Thalidomide—Hepatitis—Omeprazole—Barrett's esophagus	0.000367	0.00212	CcSEcCtD
Thalidomide—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000365	0.00211	CcSEcCtD
Thalidomide—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000365	0.00211	CcSEcCtD
Thalidomide—Pharyngitis—Omeprazole—Barrett's esophagus	0.000364	0.0021	CcSEcCtD
Thalidomide—Pharyngitis—Esomeprazole—Barrett's esophagus	0.000364	0.0021	CcSEcCtD
Thalidomide—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000362	0.00209	CcSEcCtD
Thalidomide—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000362	0.00209	CcSEcCtD
Thalidomide—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000361	0.00208	CcSEcCtD
Thalidomide—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000361	0.00208	CcSEcCtD
Thalidomide—Urethral disorder—Omeprazole—Barrett's esophagus	0.000359	0.00207	CcSEcCtD
Thalidomide—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000359	0.00207	CcSEcCtD
Thalidomide—Visual impairment—Esomeprazole—Barrett's esophagus	0.000353	0.00204	CcSEcCtD
Thalidomide—Visual impairment—Omeprazole—Barrett's esophagus	0.000353	0.00204	CcSEcCtD
Thalidomide—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000347	0.002	CcSEcCtD
Thalidomide—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000347	0.002	CcSEcCtD
Thalidomide—Eye disorder—Esomeprazole—Barrett's esophagus	0.000343	0.00198	CcSEcCtD
Thalidomide—Eye disorder—Omeprazole—Barrett's esophagus	0.000343	0.00198	CcSEcCtD
Thalidomide—Tinnitus—Omeprazole—Barrett's esophagus	0.000342	0.00197	CcSEcCtD
Thalidomide—Tinnitus—Esomeprazole—Barrett's esophagus	0.000342	0.00197	CcSEcCtD
Thalidomide—Immune system disorder—Omeprazole—Barrett's esophagus	0.000331	0.00191	CcSEcCtD
Thalidomide—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000331	0.00191	CcSEcCtD
Thalidomide—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000331	0.00191	CcSEcCtD
Thalidomide—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000331	0.00191	CcSEcCtD
Thalidomide—Chills—Omeprazole—Barrett's esophagus	0.000329	0.0019	CcSEcCtD
Thalidomide—Chills—Esomeprazole—Barrett's esophagus	0.000329	0.0019	CcSEcCtD
Thalidomide—Alopecia—Esomeprazole—Barrett's esophagus	0.000324	0.00187	CcSEcCtD
Thalidomide—Alopecia—Omeprazole—Barrett's esophagus	0.000324	0.00187	CcSEcCtD
Thalidomide—Mental disorder—Esomeprazole—Barrett's esophagus	0.000321	0.00185	CcSEcCtD
Thalidomide—Mental disorder—Omeprazole—Barrett's esophagus	0.000321	0.00185	CcSEcCtD
Thalidomide—Malnutrition—Esomeprazole—Barrett's esophagus	0.000319	0.00184	CcSEcCtD
Thalidomide—Malnutrition—Omeprazole—Barrett's esophagus	0.000319	0.00184	CcSEcCtD
Thalidomide—Flatulence—Esomeprazole—Barrett's esophagus	0.000315	0.00182	CcSEcCtD
Thalidomide—Flatulence—Omeprazole—Barrett's esophagus	0.000315	0.00182	CcSEcCtD
Thalidomide—Tension—Omeprazole—Barrett's esophagus	0.000313	0.00181	CcSEcCtD
Thalidomide—Tension—Esomeprazole—Barrett's esophagus	0.000313	0.00181	CcSEcCtD
Thalidomide—Dysgeusia—Esomeprazole—Barrett's esophagus	0.000313	0.0018	CcSEcCtD
Thalidomide—Dysgeusia—Omeprazole—Barrett's esophagus	0.000313	0.0018	CcSEcCtD
Thalidomide—Nervousness—Esomeprazole—Barrett's esophagus	0.00031	0.00179	CcSEcCtD
Thalidomide—Nervousness—Omeprazole—Barrett's esophagus	0.00031	0.00179	CcSEcCtD
Thalidomide—Back pain—Omeprazole—Barrett's esophagus	0.000309	0.00178	CcSEcCtD
Thalidomide—Back pain—Esomeprazole—Barrett's esophagus	0.000309	0.00178	CcSEcCtD
Thalidomide—Muscle spasms—Esomeprazole—Barrett's esophagus	0.000307	0.00177	CcSEcCtD
Thalidomide—Muscle spasms—Omeprazole—Barrett's esophagus	0.000307	0.00177	CcSEcCtD
Thalidomide—Vision blurred—Esomeprazole—Barrett's esophagus	0.000301	0.00174	CcSEcCtD
Thalidomide—Vision blurred—Omeprazole—Barrett's esophagus	0.000301	0.00174	CcSEcCtD
Thalidomide—Tremor—Esomeprazole—Barrett's esophagus	0.000299	0.00173	CcSEcCtD
Thalidomide—Tremor—Omeprazole—Barrett's esophagus	0.000299	0.00173	CcSEcCtD
Thalidomide—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000296	0.00171	CcSEcCtD
Thalidomide—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000296	0.00171	CcSEcCtD
Thalidomide—Anaemia—Omeprazole—Barrett's esophagus	0.000295	0.0017	CcSEcCtD
Thalidomide—Anaemia—Esomeprazole—Barrett's esophagus	0.000295	0.0017	CcSEcCtD
Thalidomide—Agitation—Omeprazole—Barrett's esophagus	0.000293	0.00169	CcSEcCtD
Thalidomide—Agitation—Esomeprazole—Barrett's esophagus	0.000293	0.00169	CcSEcCtD
Thalidomide—Angioedema—Omeprazole—Barrett's esophagus	0.000292	0.00168	CcSEcCtD
Thalidomide—Angioedema—Esomeprazole—Barrett's esophagus	0.000292	0.00168	CcSEcCtD
Thalidomide—Malaise—Esomeprazole—Barrett's esophagus	0.000288	0.00166	CcSEcCtD
Thalidomide—Malaise—Omeprazole—Barrett's esophagus	0.000288	0.00166	CcSEcCtD
Thalidomide—Vertigo—Esomeprazole—Barrett's esophagus	0.000287	0.00166	CcSEcCtD
Thalidomide—Vertigo—Omeprazole—Barrett's esophagus	0.000287	0.00166	CcSEcCtD
Thalidomide—Leukopenia—Esomeprazole—Barrett's esophagus	0.000286	0.00165	CcSEcCtD
Thalidomide—Leukopenia—Omeprazole—Barrett's esophagus	0.000286	0.00165	CcSEcCtD
Thalidomide—Palpitations—Esomeprazole—Barrett's esophagus	0.000282	0.00163	CcSEcCtD
Thalidomide—Palpitations—Omeprazole—Barrett's esophagus	0.000282	0.00163	CcSEcCtD
Thalidomide—Cough—Omeprazole—Barrett's esophagus	0.000279	0.00161	CcSEcCtD
Thalidomide—Cough—Esomeprazole—Barrett's esophagus	0.000279	0.00161	CcSEcCtD
Thalidomide—Hypertension—Esomeprazole—Barrett's esophagus	0.000276	0.00159	CcSEcCtD
Thalidomide—Hypertension—Omeprazole—Barrett's esophagus	0.000276	0.00159	CcSEcCtD
Thalidomide—Arthralgia—Esomeprazole—Barrett's esophagus	0.000272	0.00157	CcSEcCtD
Thalidomide—Chest pain—Esomeprazole—Barrett's esophagus	0.000272	0.00157	CcSEcCtD
Thalidomide—Myalgia—Esomeprazole—Barrett's esophagus	0.000272	0.00157	CcSEcCtD
Thalidomide—Myalgia—Omeprazole—Barrett's esophagus	0.000272	0.00157	CcSEcCtD
Thalidomide—Chest pain—Omeprazole—Barrett's esophagus	0.000272	0.00157	CcSEcCtD
Thalidomide—Arthralgia—Omeprazole—Barrett's esophagus	0.000272	0.00157	CcSEcCtD
Thalidomide—Anxiety—Esomeprazole—Barrett's esophagus	0.000271	0.00156	CcSEcCtD
Thalidomide—Anxiety—Omeprazole—Barrett's esophagus	0.000271	0.00156	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00027	0.00156	CcSEcCtD
Thalidomide—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00027	0.00156	CcSEcCtD
Thalidomide—Discomfort—Esomeprazole—Barrett's esophagus	0.000269	0.00155	CcSEcCtD
Thalidomide—Discomfort—Omeprazole—Barrett's esophagus	0.000269	0.00155	CcSEcCtD
Thalidomide—Dry mouth—Esomeprazole—Barrett's esophagus	0.000266	0.00153	CcSEcCtD
Thalidomide—Dry mouth—Omeprazole—Barrett's esophagus	0.000266	0.00153	CcSEcCtD
Thalidomide—Confusional state—Omeprazole—Barrett's esophagus	0.000263	0.00152	CcSEcCtD
Thalidomide—Confusional state—Esomeprazole—Barrett's esophagus	0.000263	0.00152	CcSEcCtD
Thalidomide—Infection—Omeprazole—Barrett's esophagus	0.000259	0.00149	CcSEcCtD
Thalidomide—Infection—Esomeprazole—Barrett's esophagus	0.000259	0.00149	CcSEcCtD
Thalidomide—Shock—Omeprazole—Barrett's esophagus	0.000256	0.00148	CcSEcCtD
Thalidomide—Shock—Esomeprazole—Barrett's esophagus	0.000256	0.00148	CcSEcCtD
Thalidomide—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.000256	0.00147	CcSEcCtD
Thalidomide—Nervous system disorder—Omeprazole—Barrett's esophagus	0.000256	0.00147	CcSEcCtD
Thalidomide—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000255	0.00147	CcSEcCtD
Thalidomide—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000255	0.00147	CcSEcCtD
Thalidomide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000255	0.00303	CbGpPWpGaD
Thalidomide—NFKB1—IL12-mediated signaling events—RELA—Barrett's esophagus	0.000255	0.00303	CbGpPWpGaD
Thalidomide—Tachycardia—Esomeprazole—Barrett's esophagus	0.000254	0.00147	CcSEcCtD
Thalidomide—Tachycardia—Omeprazole—Barrett's esophagus	0.000254	0.00147	CcSEcCtD
Thalidomide—Skin disorder—Omeprazole—Barrett's esophagus	0.000253	0.00146	CcSEcCtD
Thalidomide—Skin disorder—Esomeprazole—Barrett's esophagus	0.000253	0.00146	CcSEcCtD
Thalidomide—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000252	0.00145	CcSEcCtD
Thalidomide—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000252	0.00145	CcSEcCtD
Thalidomide—CYP1A2—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000252	0.00299	CbGpPWpGaD
Thalidomide—NFKB1—Fc-epsilon receptor I signaling in mast cells—RELA—Barrett's esophagus	0.000251	0.00299	CbGpPWpGaD
Thalidomide—Anorexia—Omeprazole—Barrett's esophagus	0.000248	0.00143	CcSEcCtD
Thalidomide—Anorexia—Esomeprazole—Barrett's esophagus	0.000248	0.00143	CcSEcCtD
Thalidomide—PTGS1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000244	0.0029	CbGpPWpGaD
Thalidomide—NFKB1—LPA receptor mediated events—RELA—Barrett's esophagus	0.000242	0.00287	CbGpPWpGaD
Thalidomide—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000242	0.00287	CbGpPWpGaD
Thalidomide—TNF—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.00024	0.00285	CbGpPWpGaD
Thalidomide—TNF—TNF receptor signaling pathway —RELA—Barrett's esophagus	0.00024	0.00285	CbGpPWpGaD
Thalidomide—NFKB1—Activation of NF-kappaB in B cells—RELA—Barrett's esophagus	0.000239	0.00284	CbGpPWpGaD
Thalidomide—NFKB1—Oncostatin M Signaling Pathway—RELA—Barrett's esophagus	0.000239	0.00284	CbGpPWpGaD
Thalidomide—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000237	0.00137	CcSEcCtD
Thalidomide—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000237	0.00137	CcSEcCtD
Thalidomide—NFKB1—AGE/RAGE pathway—RELA—Barrett's esophagus	0.000236	0.0028	CbGpPWpGaD
Thalidomide—NFKB1—Cytosolic sensors of pathogen-associated DNA—RELA—Barrett's esophagus	0.000236	0.0028	CbGpPWpGaD
Thalidomide—NFKB1—Folate Metabolism—RELA—Barrett's esophagus	0.000236	0.0028	CbGpPWpGaD
Thalidomide—Insomnia—Omeprazole—Barrett's esophagus	0.000236	0.00136	CcSEcCtD
Thalidomide—Insomnia—Esomeprazole—Barrett's esophagus	0.000236	0.00136	CcSEcCtD
Thalidomide—Paraesthesia—Omeprazole—Barrett's esophagus	0.000234	0.00135	CcSEcCtD
Thalidomide—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000234	0.00135	CcSEcCtD
Thalidomide—TNF—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000233	0.00277	CbGpPWpGaD
Thalidomide—NFKB1—BCR signaling pathway—RELA—Barrett's esophagus	0.000233	0.00277	CbGpPWpGaD
Thalidomide—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	0.000233	0.00277	CbGpPWpGaD
Thalidomide—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000232	0.00134	CcSEcCtD
Thalidomide—Dyspnoea—Omeprazole—Barrett's esophagus	0.000232	0.00134	CcSEcCtD
Thalidomide—TNF—Ceramide signaling pathway—RELA—Barrett's esophagus	0.000232	0.00276	CbGpPWpGaD
Thalidomide—Somnolence—Omeprazole—Barrett's esophagus	0.000232	0.00134	CcSEcCtD
Thalidomide—Somnolence—Esomeprazole—Barrett's esophagus	0.000232	0.00134	CcSEcCtD
Thalidomide—Dyspepsia—Omeprazole—Barrett's esophagus	0.000229	0.00132	CcSEcCtD
Thalidomide—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000229	0.00132	CcSEcCtD
Thalidomide—NFKB1—LPA receptor mediated events—CXCL8—Barrett's esophagus	0.000228	0.00271	CbGpPWpGaD
Thalidomide—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000226	0.00131	CcSEcCtD
Thalidomide—Decreased appetite—Omeprazole—Barrett's esophagus	0.000226	0.00131	CcSEcCtD
Thalidomide—NFKB1—Signaling events mediated by HDAC Class I—RELA—Barrett's esophagus	0.000225	0.00268	CbGpPWpGaD
Thalidomide—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000225	0.0013	CcSEcCtD
Thalidomide—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000225	0.0013	CcSEcCtD
Thalidomide—Fatigue—Omeprazole—Barrett's esophagus	0.000225	0.0013	CcSEcCtD
Thalidomide—Fatigue—Esomeprazole—Barrett's esophagus	0.000225	0.0013	CcSEcCtD
Thalidomide—TNF—Angiopoietin receptor Tie2-mediated signaling—RELA—Barrett's esophagus	0.000224	0.00267	CbGpPWpGaD
Thalidomide—Constipation—Esomeprazole—Barrett's esophagus	0.000223	0.00129	CcSEcCtD
Thalidomide—Pain—Omeprazole—Barrett's esophagus	0.000223	0.00129	CcSEcCtD
Thalidomide—Constipation—Omeprazole—Barrett's esophagus	0.000223	0.00129	CcSEcCtD
Thalidomide—Pain—Esomeprazole—Barrett's esophagus	0.000223	0.00129	CcSEcCtD
Thalidomide—TNF—Vitamin B12 Metabolism—RELA—Barrett's esophagus	0.000221	0.00263	CbGpPWpGaD
Thalidomide—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.00022	0.00261	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000218	0.0026	CbGpPWpGaD
Thalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—Barrett's esophagus	0.000218	0.00259	CbGpPWpGaD
Thalidomide—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000215	0.00124	CcSEcCtD
Thalidomide—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000215	0.00124	CcSEcCtD
Thalidomide—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000213	0.00123	CcSEcCtD
Thalidomide—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000213	0.00123	CcSEcCtD
Thalidomide—NFKB1—Leptin signaling pathway—RELA—Barrett's esophagus	0.000213	0.00253	CbGpPWpGaD
Thalidomide—NFKB1—TRAF6 Mediated Induction of proinflammatory cytokines—RELA—Barrett's esophagus	0.000213	0.00253	CbGpPWpGaD
Thalidomide—TNF—Signaling events mediated by HDAC Class I—PPARG—Barrett's esophagus	0.000212	0.00252	CbGpPWpGaD
Thalidomide—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.000212	0.00251	CbGpPWpGaD
Thalidomide—NFKB1—Transcriptional regulation of white adipocyte differentiation—RELA—Barrett's esophagus	0.000209	0.00248	CbGpPWpGaD
Thalidomide—Urticaria—Omeprazole—Barrett's esophagus	0.000207	0.00119	CcSEcCtD
Thalidomide—Urticaria—Esomeprazole—Barrett's esophagus	0.000207	0.00119	CcSEcCtD
Thalidomide—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000207	0.00246	CbGpPWpGaD
Thalidomide—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000206	0.00119	CcSEcCtD
Thalidomide—Body temperature increased—Omeprazole—Barrett's esophagus	0.000206	0.00119	CcSEcCtD
Thalidomide—Abdominal pain—Omeprazole—Barrett's esophagus	0.000206	0.00119	CcSEcCtD
Thalidomide—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000206	0.00119	CcSEcCtD
Thalidomide—NFKB1—RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways—RELA—Barrett's esophagus	0.000202	0.0024	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis—CDKN2A—Barrett's esophagus	0.000202	0.0024	CbGpPWpGaD
Thalidomide—NFKB1—DNA Damage Response (only ATM dependent)—APC—Barrett's esophagus	0.000202	0.0024	CbGpPWpGaD
Thalidomide—NFKB1—p75 NTR receptor-mediated signalling—RELA—Barrett's esophagus	0.000198	0.00236	CbGpPWpGaD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.000198	0.00236	CbGpPWpGaD
Thalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—PPARG—Barrett's esophagus	0.000196	0.00233	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	0.000196	0.00232	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis—RELA—Barrett's esophagus	0.000195	0.00231	CbGpPWpGaD
Thalidomide—NFKB1—MyD88 cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000193	0.00229	CbGpPWpGaD
Thalidomide—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000192	0.00111	CcSEcCtD
Thalidomide—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000192	0.00111	CcSEcCtD
Thalidomide—NFKB1—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—RELA—Barrett's esophagus	0.000191	0.00227	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis Modulation and Signaling—CDKN2A—Barrett's esophagus	0.00019	0.00225	CbGpPWpGaD
Thalidomide—NFKB1—MyD88 dependent cascade initiated on endosome—RELA—Barrett's esophagus	0.000187	0.00223	CbGpPWpGaD
Thalidomide—NFKB1—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000187	0.00223	CbGpPWpGaD
Thalidomide—Asthenia—Omeprazole—Barrett's esophagus	0.000187	0.00108	CcSEcCtD
Thalidomide—Asthenia—Esomeprazole—Barrett's esophagus	0.000187	0.00108	CcSEcCtD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.000187	0.00222	CbGpPWpGaD
Thalidomide—Pruritus—Esomeprazole—Barrett's esophagus	0.000184	0.00106	CcSEcCtD
Thalidomide—Pruritus—Omeprazole—Barrett's esophagus	0.000184	0.00106	CcSEcCtD
Thalidomide—NFKB1—TCR Signaling Pathway—RELA—Barrett's esophagus	0.000184	0.00219	CbGpPWpGaD
Thalidomide—CYP2E1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000183	0.00217	CbGpPWpGaD
Thalidomide—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	0.000182	0.00217	CbGpPWpGaD
Thalidomide—NFKB1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000182	0.00216	CbGpPWpGaD
Thalidomide—NFKB1—Corticotropin-releasing hormone—RELA—Barrett's esophagus	0.000181	0.00215	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—RELA—Barrett's esophagus	0.000181	0.00215	CbGpPWpGaD
Thalidomide—CYP2E1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00018	0.00214	CbGpPWpGaD
Thalidomide—TNF—Folate Metabolism—RELA—Barrett's esophagus	0.00018	0.00214	CbGpPWpGaD
Thalidomide—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00018	0.00214	CbGpPWpGaD
Thalidomide—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000178	0.00103	CcSEcCtD
Thalidomide—Diarrhoea—Omeprazole—Barrett's esophagus	0.000178	0.00103	CcSEcCtD
Thalidomide—NFKB1—MyD88:Mal cascade initiated on plasma membrane—RELA—Barrett's esophagus	0.000178	0.00211	CbGpPWpGaD
Thalidomide—NFKB1—B Cell Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000173	0.00206	CbGpPWpGaD
Thalidomide—Dizziness—Esomeprazole—Barrett's esophagus	0.000172	0.000994	CcSEcCtD
Thalidomide—Dizziness—Omeprazole—Barrett's esophagus	0.000172	0.000994	CcSEcCtD
Thalidomide—CYP1A1—Biological oxidations—CYP26A1—Barrett's esophagus	0.000172	0.00205	CbGpPWpGaD
Thalidomide—TNF—Signaling events mediated by HDAC Class I—RELA—Barrett's esophagus	0.000171	0.00204	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—Barrett's esophagus	0.000171	0.00204	CbGpPWpGaD
Thalidomide—NFKB1—MyD88-independent cascade—RELA—Barrett's esophagus	0.000171	0.00203	CbGpPWpGaD
Thalidomide—NFKB1—Corticotropin-releasing hormone—CXCL8—Barrett's esophagus	0.00017	0.00203	CbGpPWpGaD
Thalidomide—PTGS1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00017	0.00202	CbGpPWpGaD
Thalidomide—CYP1A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.00017	0.00202	CbGpPWpGaD
Thalidomide—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—CDKN2A—Barrett's esophagus	0.000169	0.00201	CbGpPWpGaD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000167	0.00198	CbGpPWpGaD
Thalidomide—Vomiting—Esomeprazole—Barrett's esophagus	0.000166	0.000956	CcSEcCtD
Thalidomide—Vomiting—Omeprazole—Barrett's esophagus	0.000166	0.000956	CcSEcCtD
Thalidomide—Rash—Omeprazole—Barrett's esophagus	0.000164	0.000948	CcSEcCtD
Thalidomide—Rash—Esomeprazole—Barrett's esophagus	0.000164	0.000948	CcSEcCtD
Thalidomide—Dermatitis—Omeprazole—Barrett's esophagus	0.000164	0.000947	CcSEcCtD
Thalidomide—Dermatitis—Esomeprazole—Barrett's esophagus	0.000164	0.000947	CcSEcCtD
Thalidomide—NFKB1—DNA Damage Response (only ATM dependent)—CDKN2A—Barrett's esophagus	0.000164	0.00195	CbGpPWpGaD
Thalidomide—Headache—Esomeprazole—Barrett's esophagus	0.000163	0.000942	CcSEcCtD
Thalidomide—Headache—Omeprazole—Barrett's esophagus	0.000163	0.000942	CcSEcCtD
Thalidomide—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—RELA—Barrett's esophagus	0.000163	0.00193	CbGpPWpGaD
Thalidomide—NFKB1—BDNF signaling pathway—APC—Barrett's esophagus	0.000162	0.00192	CbGpPWpGaD
Thalidomide—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—Barrett's esophagus	0.000162	0.00192	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by Interleukins—RELA—Barrett's esophagus	0.000159	0.00189	CbGpPWpGaD
Thalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—RELA—Barrett's esophagus	0.000159	0.00189	CbGpPWpGaD
Thalidomide—NFKB1—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.000157	0.00187	CbGpPWpGaD
Thalidomide—Nausea—Esomeprazole—Barrett's esophagus	0.000155	0.000893	CcSEcCtD
Thalidomide—Nausea—Omeprazole—Barrett's esophagus	0.000155	0.000893	CcSEcCtD
Thalidomide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000155	0.00184	CbGpPWpGaD
Thalidomide—TNF—Apoptosis—CDKN2A—Barrett's esophagus	0.000154	0.00183	CbGpPWpGaD
Thalidomide—NFKB1—Activated TLR4 signalling—RELA—Barrett's esophagus	0.000153	0.00182	CbGpPWpGaD
Thalidomide—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—CXCL8—Barrett's esophagus	0.000153	0.00182	CbGpPWpGaD
Thalidomide—FGFR2—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	0.000149	0.00178	CbGpPWpGaD
Thalidomide—PTGS2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000148	0.00176	CbGpPWpGaD
Thalidomide—TNF—Apoptosis—RELA—Barrett's esophagus	0.000148	0.00176	CbGpPWpGaD
Thalidomide—TNF—Allograft Rejection—CXCL8—Barrett's esophagus	0.000147	0.00174	CbGpPWpGaD
Thalidomide—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—RELA—Barrett's esophagus	0.000144	0.00172	CbGpPWpGaD
Thalidomide—TNF—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000143	0.0017	CbGpPWpGaD
Thalidomide—CYP2C19—Biological oxidations—CYP26A1—Barrett's esophagus	0.000141	0.00167	CbGpPWpGaD
Thalidomide—CYP2C19—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000139	0.00165	CbGpPWpGaD
Thalidomide—TNF—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000139	0.00165	CbGpPWpGaD
Thalidomide—NFKB1—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000138	0.00164	CbGpPWpGaD
Thalidomide—NFKB1—Folate Metabolism—TP53—Barrett's esophagus	0.000136	0.00162	CbGpPWpGaD
Thalidomide—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	0.000135	0.0016	CbGpPWpGaD
Thalidomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000132	0.00157	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000132	0.00157	CbGpPWpGaD
Thalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—Barrett's esophagus	0.000131	0.00155	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	0.00013	0.00155	CbGpPWpGaD
Thalidomide—TNF—Adipogenesis—PPARG—Barrett's esophagus	0.000129	0.00153	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	0.000129	0.00153	CbGpPWpGaD
Thalidomide—NFKB1—Toll-Like Receptors Cascades—RELA—Barrett's esophagus	0.000129	0.00153	CbGpPWpGaD
Thalidomide—CYP2C9—Biological oxidations—CYP26A1—Barrett's esophagus	0.000128	0.00153	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000128	0.00152	CbGpPWpGaD
Thalidomide—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000128	0.00152	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—RELA—Barrett's esophagus	0.000127	0.00151	CbGpPWpGaD
Thalidomide—CYP2C9—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000127	0.00151	CbGpPWpGaD
Thalidomide—NFKB1—BDNF signaling pathway—RELA—Barrett's esophagus	0.000126	0.0015	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000124	0.00147	CbGpPWpGaD
Thalidomide—NFKB1—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	0.000123	0.00146	CbGpPWpGaD
Thalidomide—CYP1A1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.00012	0.00142	CbGpPWpGaD
Thalidomide—TNF—Toll-like Receptor Signaling Pathway—CXCL8—Barrett's esophagus	0.00012	0.00142	CbGpPWpGaD
Thalidomide—TNF—Apoptosis—APC—Barrett's esophagus	0.000116	0.00138	CbGpPWpGaD
Thalidomide—NFKB1—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	0.000115	0.00136	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis—TP53—Barrett's esophagus	0.000113	0.00134	CbGpPWpGaD
Thalidomide—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000112	0.00133	CbGpPWpGaD
Thalidomide—NFKB1—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	0.000112	0.00133	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—RELA—Barrett's esophagus	0.000111	0.00132	CbGpPWpGaD
Thalidomide—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	0.00011	0.0013	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—PTGS2—Barrett's esophagus	0.00011	0.0013	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	0.000109	0.00129	CbGpPWpGaD
Thalidomide—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000108	0.00129	CbGpPWpGaD
Thalidomide—PTGS1—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	0.000108	0.00128	CbGpPWpGaD
Thalidomide—NFKB1—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000107	0.00127	CbGpPWpGaD
Thalidomide—NFKB1—Cellular Senescence—CDKN2A—Barrett's esophagus	0.000107	0.00127	CbGpPWpGaD
Thalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—Barrett's esophagus	0.000107	0.00127	CbGpPWpGaD
Thalidomide—FGFR2—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	0.000107	0.00127	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—CXCL8—Barrett's esophagus	0.000106	0.00126	CbGpPWpGaD
Thalidomide—NFKB1—Apoptosis Modulation and Signaling—TP53—Barrett's esophagus	0.000106	0.00125	CbGpPWpGaD
Thalidomide—TNF—Folate Metabolism—TP53—Barrett's esophagus	0.000104	0.00124	CbGpPWpGaD
Thalidomide—NFKB1—Cellular Senescence—RELA—Barrett's esophagus	0.000103	0.00122	CbGpPWpGaD
Thalidomide—FGFR2—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	0.000102	0.00121	CbGpPWpGaD
Thalidomide—NFKB1—B Cell Activation—RELA—Barrett's esophagus	9.92e-05	0.00118	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—RELA—Barrett's esophagus	9.91e-05	0.00118	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	9.83e-05	0.00117	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	9.83e-05	0.00117	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	9.8e-05	0.00116	CbGpPWpGaD
Thalidomide—CYP2C19—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.8e-05	0.00116	CbGpPWpGaD
Thalidomide—NFKB1—Cellular Senescence—CXCL8—Barrett's esophagus	9.71e-05	0.00115	CbGpPWpGaD
Thalidomide—PTGS2—C-MYB transcription factor network—CDKN2A—Barrett's esophagus	9.53e-05	0.00113	CbGpPWpGaD
Thalidomide—FGFR2—B Cell Activation—RELA—Barrett's esophagus	9.41e-05	0.00112	CbGpPWpGaD
Thalidomide—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—Barrett's esophagus	9.34e-05	0.00111	CbGpPWpGaD
Thalidomide—NFKB1—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	9.13e-05	0.00109	CbGpPWpGaD
Thalidomide—TNF—Alzheimers Disease—TP53—Barrett's esophagus	9e-05	0.00107	CbGpPWpGaD
Thalidomide—CYP2C9—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	8.93e-05	0.00106	CbGpPWpGaD
Thalidomide—PTGS2—Selenium Micronutrient Network—RELA—Barrett's esophagus	8.83e-05	0.00105	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.72e-05	0.00104	CbGpPWpGaD
Thalidomide—TNF—Apoptosis—TP53—Barrett's esophagus	8.57e-05	0.00102	CbGpPWpGaD
Thalidomide—TNF—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	8.51e-05	0.00101	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	8.4e-05	0.000998	CbGpPWpGaD
Thalidomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	8.16e-05	0.00097	CbGpPWpGaD
Thalidomide—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	8.1e-05	0.000963	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—CDKN2A—Barrett's esophagus	8.09e-05	0.000961	CbGpPWpGaD
Thalidomide—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	7.93e-05	0.000942	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—RELA—Barrett's esophagus	7.78e-05	0.000925	CbGpPWpGaD
Thalidomide—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	7.63e-05	0.000907	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	7.46e-05	0.000887	CbGpPWpGaD
Thalidomide—NFKB1—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	7.43e-05	0.000882	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—CXCL8—Barrett's esophagus	7.33e-05	0.000872	CbGpPWpGaD
Thalidomide—NFKB1—Signaling by NGF—RELA—Barrett's esophagus	7.3e-05	0.000868	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.14e-05	0.000848	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	7.04e-05	0.000836	CbGpPWpGaD
Thalidomide—FGFR2—Signaling by NGF—RELA—Barrett's esophagus	6.93e-05	0.000823	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—CXCL8—Barrett's esophagus	6.58e-05	0.000782	CbGpPWpGaD
Thalidomide—TNF—Spinal Cord Injury—TP53—Barrett's esophagus	6.53e-05	0.000776	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	6.51e-05	0.000773	CbGpPWpGaD
Thalidomide—NFKB1—MAPK Signaling Pathway—TP53—Barrett's esophagus	6.46e-05	0.000768	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	6.08e-05	0.000723	CbGpPWpGaD
Thalidomide—NFKB1—Cellular Senescence—TP53—Barrett's esophagus	5.96e-05	0.000708	CbGpPWpGaD
Thalidomide—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	5.83e-05	0.000693	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—PPARG—Barrett's esophagus	5.82e-05	0.000692	CbGpPWpGaD
Thalidomide—FGFR2—Disease—SLC9A1—Barrett's esophagus	5.75e-05	0.000683	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	5.56e-05	0.000661	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—GAST—Barrett's esophagus	5.53e-05	0.000658	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PTGES—Barrett's esophagus	5.51e-05	0.000655	CbGpPWpGaD
Thalidomide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	5.46e-05	0.000649	CbGpPWpGaD
Thalidomide—TNF—Apoptosis—TP53—Barrett's esophagus	5.25e-05	0.000624	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—GAST—Barrett's esophagus	5.25e-05	0.000624	CbGpPWpGaD
Thalidomide—TNF—MAPK Signaling Pathway—TP53—Barrett's esophagus	4.92e-05	0.000585	CbGpPWpGaD
Thalidomide—NFKB1—Developmental Biology—RELA—Barrett's esophagus	4.71e-05	0.00056	CbGpPWpGaD
Thalidomide—NFKB1—Cellular responses to stress—TP53—Barrett's esophagus	4.5e-05	0.000535	CbGpPWpGaD
Thalidomide—TNF—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	4.44e-05	0.000528	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—PPARG—Barrett's esophagus	4.44e-05	0.000527	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PTGES—Barrett's esophagus	4.38e-05	0.00052	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—HGF—Barrett's esophagus	4.18e-05	0.000497	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	4.18e-05	0.000497	CbGpPWpGaD
Thalidomide—NFKB1—Innate Immune System—RELA—Barrett's esophagus	4.16e-05	0.000495	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTGES—Barrett's esophagus	4.12e-05	0.00049	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTGES—Barrett's esophagus	4.11e-05	0.000489	CbGpPWpGaD
Thalidomide—PTGS2—Spinal Cord Injury—TP53—Barrett's esophagus	4.04e-05	0.00048	CbGpPWpGaD
Thalidomide—NFKB1—Adaptive Immune System—RELA—Barrett's esophagus	4e-05	0.000475	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—HGF—Barrett's esophagus	3.97e-05	0.000471	CbGpPWpGaD
Thalidomide—FGFR2—Innate Immune System—RELA—Barrett's esophagus	3.95e-05	0.00047	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTGES—Barrett's esophagus	3.88e-05	0.000462	CbGpPWpGaD
Thalidomide—FGFR2—Adaptive Immune System—RELA—Barrett's esophagus	3.79e-05	0.000451	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—SST—Barrett's esophagus	3.79e-05	0.000451	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—SST—Barrett's esophagus	3.6e-05	0.000428	CbGpPWpGaD
Thalidomide—TNF—Developmental Biology—RELA—Barrett's esophagus	3.59e-05	0.000427	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—CYP26A1—Barrett's esophagus	3.32e-05	0.000394	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTGES—Barrett's esophagus	3.18e-05	0.000378	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—CYP26A1—Barrett's esophagus	3.12e-05	0.000371	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	3.12e-05	0.00037	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.09e-05	0.000367	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	3.01e-05	0.000358	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	2.94e-05	0.00035	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTGES—Barrett's esophagus	2.9e-05	0.000344	CbGpPWpGaD
Thalidomide—PTGS2—Disease—SLC9A1—Barrett's esophagus	2.85e-05	0.000339	CbGpPWpGaD
Thalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.75e-05	0.000327	CbGpPWpGaD
Thalidomide—FGFR2—Disease—APC—Barrett's esophagus	2.72e-05	0.000323	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTGES—Barrett's esophagus	2.48e-05	0.000294	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.45e-05	0.000291	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.43e-05	0.000289	CbGpPWpGaD
Thalidomide—NFKB1—Immune System—RELA—Barrett's esophagus	2.43e-05	0.000288	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—CYP26A1—Barrett's esophagus	2.41e-05	0.000286	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—SLC9A1—Barrett's esophagus	2.39e-05	0.000284	CbGpPWpGaD
Thalidomide—FGFR2—Immune System—RELA—Barrett's esophagus	2.3e-05	0.000273	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—SLC9A1—Barrett's esophagus	2.25e-05	0.000267	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	2.25e-05	0.000267	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.2e-05	0.000261	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.17e-05	0.000258	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	2.12e-05	0.000252	CbGpPWpGaD
Thalidomide—FGFR2—Disease—PTGS2—Barrett's esophagus	2.06e-05	0.000245	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—APC—Barrett's esophagus	2.01e-05	0.000238	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—APC—Barrett's esophagus	1.9e-05	0.000226	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	1.88e-05	0.000223	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.78e-05	0.000212	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—SLC9A1—Barrett's esophagus	1.74e-05	0.000206	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.71e-05	0.000203	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.62e-05	0.000193	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	1.58e-05	0.000188	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—RELA—Barrett's esophagus	1.57e-05	0.000186	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—RELA—Barrett's esophagus	1.49e-05	0.000177	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—CXCL8—Barrett's esophagus	1.48e-05	0.000176	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—CXCL8—Barrett's esophagus	1.4e-05	0.000167	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.4e-05	0.000166	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.39e-05	0.000165	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PPARG—Barrett's esophagus	1.37e-05	0.000163	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.35e-05	0.000161	CbGpPWpGaD
Thalidomide—PTGS2—Disease—APC—Barrett's esophagus	1.35e-05	0.00016	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.28e-05	0.000152	CbGpPWpGaD
Thalidomide—PTGS2—Metabolism—PPARG—Barrett's esophagus	1.09e-05	0.00013	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.09e-05	0.00013	CbGpPWpGaD
Thalidomide—PTGS1—Metabolism—PTGS2—Barrett's esophagus	1.08e-05	0.000129	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PPARG—Barrett's esophagus	1.03e-05	0.000122	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PPARG—Barrett's esophagus	1.03e-05	0.000122	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PPARG—Barrett's esophagus	9.69e-06	0.000115	CbGpPWpGaD
Thalidomide—NFKB1—Signaling Pathways—TP53—Barrett's esophagus	9.07e-06	0.000108	CbGpPWpGaD
Thalidomide—FGFR2—Signaling Pathways—TP53—Barrett's esophagus	8.6e-06	0.000102	CbGpPWpGaD
Thalidomide—CYP2E1—Metabolism—PTGS2—Barrett's esophagus	8.08e-06	9.61e-05	CbGpPWpGaD
Thalidomide—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	8.07e-06	9.59e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PPARG—Barrett's esophagus	7.93e-06	9.42e-05	CbGpPWpGaD
Thalidomide—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	7.62e-06	9.06e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PPARG—Barrett's esophagus	7.23e-06	8.59e-05	CbGpPWpGaD
Thalidomide—CYP2C19—Metabolism—PTGS2—Barrett's esophagus	6.24e-06	7.41e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PPARG—Barrett's esophagus	6.18e-06	7.34e-05	CbGpPWpGaD
Thalidomide—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	5.69e-06	6.76e-05	CbGpPWpGaD
Thalidomide—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	4.86e-06	5.77e-05	CbGpPWpGaD
